Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025
Semaglutide reduces blood glucose through a mechanism where it stimulates insulin secretion and lowers Glc secretion, both in a glucose-dependent manner
GHK-Cu: The Regenerative Signal GHK-Cu is a copper-binding tripeptide that occurs naturally in human plasma, but it declines as we age
US$ 22.58
US$ 28.22
US$ 23.74
US$ 24.98
